Lastly, we find it noteworthy that the triple-negative group shows low levels of PLT-binding, whereas MPN with MPL mutations – another thrombopoietin receptor mutation - exhibited high binding levels. The gene discussed is MPL; the disease is myeloproliferative neoplasm.